Medical Imaging

Physicians utilize medical imaging to see inside the body to diagnose and treat patients. This includes computed tomography (CT), magnetic resonance imaging (MRI), X-ray, ultrasound, fluoroscopy, angiography,  and the nuclear imaging modalities of PET and SPECT. 

The economic impact of MR on heart failure patients

Newly diagnosed HF patients with concomitant mitral regurgitation can expect more admissions, longer hospital stays and pricier medical bills than HF patients without MR, according to an analysis published in the American Journal of Cardiology.

Thumbnail

How MRI scans can dramatically improve prostate cancer diagnosis

Multiparametric MRI (mpMRI) scans and targeted biopsies can improve the detection of clinically significant prostate cancer, according to new research published in JAMA Network Open.

Thumbnail

USPSTF: Asymptomatic adults shouldn’t be screened for pancreatic cancer

The U.S. Preventative Services Task Force (USPSTF) has released a statement recommending against screening for pancreatic cancer in asymptomatic adults.

Thumbnail

No evidence IV contrast causes renal damage in patients with kidney disease, study finds

A new study found that chronic kidney disease patients who received IV contrast-enhanced imaging faced no more risk of developing contrast-induced nephropathy than those who did not receive contrast material.

Thumbnail

Should everyone at risk of Alzheimer’s get a brain scan?

A recent story in the New York Times analyzed the positives and potential negatives of undergoing an amyloid PET scan to gain insight into one’s risk of developing Alzheimer’s.

Thumbnail

ASRT backs radiopharmaceutical reform bill

The American Society of Radiologic Technologists (ASRT) voiced their support for recent legislation that seeks to improve patient-access to radiopharmaceuticals in an Aug. 1 statement.

Thumbnail

Novel PET method improves detection of prostate cancer recurrence

Researchers compared prostate-specific membrane antigen (PSMA) PET/CT to traditional 18F-fluciclovine PET/CT for the detection of biochemically recurrent prostate cancer.

Thumbnail

FDA shares new guidance document on MRI safety

The FDA has published a new guidance document focused on making improvements to the overall safety of MR environments and MRI-related medical device labeling.